Recent medical advancements span oncology, dermatology, autoimmune research, and healthcare technology.

Three new clinical trials for hidradenitis suppurativa have identified promising targeted therapies that successfully interrupt the pathophysiology of the disease.

A retrospective real-world study confirms that avelumab remains an effective treatment for Merkel cell carcinoma, extending results to populations often excluded from traditional clinical trials.

Researchers are investigating safety concerns after three patient deaths led to the suspension of several clinical trials involving CAR T-cell therapy for autoimmune diseases.

A novel smartphone-based 3D imaging tool demonstrates accuracy comparable to specialists in assessing ptosis, offering a potential screening aid for surgical decisions.

Analysis of UK Biobank data reveals that retinal neurodegeneration can occur at blood sugar levels currently below the clinical threshold for prediabetes diagnosis.

Healthcare cybersecurity experts are warning of increased risks following a high-profile AI-assisted cyberattack on an Australian government healthcare website.

Implanting cesium-131 tiles during brain metastasis surgery significantly improves surgical bed control and extends survival compared to standard postoperative stereotactic radiation.

The monoclonal antibody daxdilimab has shown positive outcomes, including reduced disease activity and a favorable safety profile, in patients with moderate-to-severe discoid lupus erythematosus.